Insider Selling: Entrada Therapeutics (NASDAQ:TRDA) Director Sells $73,458.00 in Stock
MarketBeat
Entrada Therapeutics, Inc. (NASDAQ:TRDA - Get Free Report) Director Kush Parmar sold 10,494 shares of the stock in a transaction that occurred on Thursday, August 6th. The stock was sold at an average price of $7.00, for a total value of $73,458.00. Following the sale, the director directly owned 2,836,098 shares in the company, valued at $19,852,686. This represents a 0.37% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
NASDAQ:TRDA